New study finds cellular immunotherapy treatment associated with improved quality of life
Feb 19, 2020
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy showed marked improvement on a variety of self-reported quality of life measures, according to a study published today in Blood Advances. The study offers evidence that CAR-T may not only extend cancer patients’ survival, but also improve their quality of life after treatment.
Statement on New ASH Clinical Practice Guidelines on Sickle Cell Disease-Related Transfusion Support
Jan 27, 2020
Today, the American Society of Hematology (ASH) released new clinical practice guidelines on Sickle Cell Disease (SCD)-Related Transfusion Support. These guidelines are part of a series of five guidelines ASH is developing on SCD to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people with SCD can make the best decisions for their care.
Minority Hematology Scholars to Study New Methods for Improving Blood Disease Treatments
Jan 23, 2020
The American Society of Hematology is pleased to announce that Gabriela Hobbs, MD, of Massachusetts General Hospital, and Oluwatoyosi Onwuemene, MD, MS, of Duke University have been selected to participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program, a partnership between ASH and the Robert Wood Johnson Foundation.